Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis
Related Experiment Video
Updated: May 30, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
1Cerebrovascular Division, Department of Neurology, Hospital Universitari del Sagrat Cor, Universitat de Barcelona, Barcelona, Spain.
Insights
Cardioembolic stroke is a severe condition with high recurrence rates. Early treatment and strict follow-up are crucial for secondary prevention, especially for patients with atrial fibrillation or heart valve issues.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Cardioembolic stroke constitutes 14-30% of ischemic strokes and is associated with significant morbidity and mortality.
- Patients with cardioembolic infarction face a high risk of early and long-term stroke recurrence.
- Prompt diagnosis and management are essential for improving patient outcomes.
Purpose of the Study:
- To provide an updated overview of the clinical features, cardiac disorders, and prognosis of cardioembolic stroke.
- To identify risk factors and clinical indicators suggestive of cardioembolic infarction.
- To discuss diagnostic methods and secondary prevention strategies.
Main Methods:
- Review of clinical features associated with cardioembolic stroke.
- Identification of common high-risk cardiac conditions.
- Discussion of diagnostic tools like echocardiography and Holter monitoring.
- Analysis of mortality rates and risk factors for recurrence.
Main Results:
- Specific clinical features suggest cardioembolic origin, while lacunar infarcts make it unlikely.
- Atrial fibrillation, recent myocardial infarction, and prosthetic valves are common high-risk conditions.
- In-hospital mortality for cardioembolic stroke is high (27.3%), with early recurrence mortality reaching 77% in some cases.
- Risk factors for early recurrence include alcohol abuse, hypertension, and valvular heart disease.
Conclusions:
- Cardioembolic stroke is a severe condition requiring immediate and appropriate management.
- Secondary prevention with anticoagulants should be initiated promptly in high-risk patients without contraindications.
- Effective management involves identifying cardiac sources and implementing rigorous secondary prevention strategies.
Abstract:
This article provides the reader with an overview and up-date of clinical features, specific cardiac disorders and prognosis of cardioembolic stroke. Cardioembolic stroke accounts for 14-30% of ischemic strokes and, in general, is a severe condition; patients with cardioembolic infarction are prone to early and long-term stroke recurrence, although recurrences may be preventable by appropriate treatment during the acute phase and strict control at follow-up. Certain clinical features are suggestive of cardioembolic infarction, including sudden onset to maximal deficit, decreased level of consciousness at onset, Wernicke's aphasia or global aphasia without hemiparesis, a Valsalva manoeuvre at the time of stroke onset, and co-occurrence of cerebral and systemic emboli. Lacunar clinical presentations, a lacunar infarct and especially multiple lacunar infarcts, make cardioembolic origin unlikely. The more common high risk cardioembolic conditions are atrial fibrillation, recent myocardial infarction, mechanical prosthetic valve, dilated myocardiopathy, and mitral rheumatic stenosis. Transthoracic and transesophageal echocardiogram can disclose structural heart diseases. Paroxysmal atrial dysrhyhtmia can be detected by Holter monitoring. In-hospital mortality in cardioembolic stroke (27.3%, in our series) is the highest as compared with other subtypes of cerebral infarction. In our experience, in-hospital mortality in patients with early embolic recurrence (within the first 7 days) was 77%. Patients with alcohol abuse, hypertension, valvular heart disease, nausea and vomiting, and previous cerebral infarction are at increased risk of early recurrent systemic embolization. Secondary prevention with anticoagulants should be started immediately if possible in patients at high risk for recurrent cardioembolic stroke in which contraindications, such as falls, poor compliance, uncontrolled epilepsy or gastrointestinal bleeding are absent.
Related Concept Videos
Ischemic Stroke l: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction Cardiac Emergencies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiovascular Drugs: Classification based on Therapeutic Indications